Ocugen (OCGN) Total Debt Growth (1y) (2015 - 2026)
Ocugen (OCGN) Total Debt Growth (1y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5.94% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ocugen |
411.07 Mn |
411.07 Mn |
- |
5.51% |
| Date | Value |
|---|
| Mar 31, 2026 |
5.51% |
| Dec 31, 2025 |
0.42% |
| Sep 30, 2025 |
883.72% |
| Jun 30, 2025 |
880.58% |
| Mar 31, 2025 |
878.05% |
| Dec 31, 2024 |
923.96% |
| Sep 30, 2024 |
4.19% |
| Jun 30, 2024 |
4.38% |
| Mar 31, 2024 |
22.26% |
| Dec 31, 2023 |
22.32% |
| Sep 30, 2023 |
22.34% |
| Jun 30, 2023 |
56.46% |
| Mar 31, 2023 |
33.68% |
| Dec 31, 2022 |
33.70% |
| Sep 30, 2022 |
33.79% |
| Jun 30, 2022 |
4.54% |
| Mar 31, 2022 |
-16.62% |
| Dec 31, 2021 |
-16.77% |
| Sep 30, 2021 |
-46.34% |
| Jun 30, 2021 |
-72.50% |
